To the Editor: We present this case to highlight the differential diagnosis of afebrile seizures in patients from many asset-poor nations. A 3-year-old Congolese girl presented with sustained loss of consciousness after a prolonged generalised seizure. She had migrated, with her family, 12 months previously after a long period in a Zambian refugee camp.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1 Child and Adolescent Health Service, Western Australian Department of Health, Perth, WA.
- 2 Queensland Institute of Medical Research, University of Queensland, Brisbane, QLD.
- 3 School of Paediatrics and Child Health, University of Western Australia, Perth, WA.
- 4 Murdoch Childrens Research Institute, Royal Children’s Hospital, Melbourne, VIC.
Correspondence: dburgner@meddent.uwa.edu.au
- 1. Schantz PM, Moore AC, Muñoz JL, et al. Neurocysticercosis in an orthodox Jewish community in New York City. N Engl J Med 1992; 327: 692-695.
- 2. Román G, Sotelo J, Del Brutto O, et al. World Federation of Neurology Research Group on Tropical Neurology. A proposal to declare neurocysticercosis an international reportable disease. Bull World Health Organ 2000; 78: 399-406.
- 3. Singhi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Child Neurol 2000; 15: 207-213.
- 4. Garcia HH, Evans CA, Nash TE, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002; 15: 747-756.
- 5. Garcia HH, Gonzalez I, Mija L. Neurocysticercosis uncovered by single-dose albendazole. N Engl J Med 2007; 356: 1277-1278.
Online responses are no longer available. Please refer to our instructions for authors page for more information.